Sponsor Pipeline

Kiniksa Pharmaceuticals International, plc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT07010159
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and…		 Enrollment increased: 165 -> 325 participants
2026-08-12 NCT07010159
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and…		 Trial sites expanded: 58 -> 62 locations
Active Trials by Phase
Phase 2/3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07010159 Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and… Pericarditis Recruiting
Phase 2
NCT07288216 Transition to KPL-387 Monotherapy Dosing & Administration Study Recurrent Pericarditis Recruiting
Not specified
NCT04687358 REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients Recurrent Pericarditis Active, Not Recruiting
Disease Areas
Heart Disease (1)
Get alerts when Kiniksa Pharmaceuticals International, plc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free